pharmatechoutlook
TECH OUTLOOKTECH OUTLOOKOCTOBER - 20215LAST WORDKashif Zuberi, Laparoendoscopic Gastrointestinal Surgeon, Sanford HealthThe New Age of Patient Treatment38Editor`s ChoiceCXO INSIGHTSCXO INSIGHTSPreclinical Expertise from Planning to Production22De-risking the Preclinical Phase of Immunotherapy Drug DevelopmentRalph Gareus, Director Business Development, The Jackson Laboratory30Can Expanding Data Sources in Pharma Lead to Faster Drug Development?James Streeter, Global VP Life Sciences Strategy, Oracle Health Sciences [NYSE:ORCL]35Rethinking Change ManagementViviane Minden, MBA, Change Management & Communications Head, Enterprise Operations Simplification, Novartis [SWX: NOVN]24Leveraging Seamless Workflows in Medical DocumentationJoshua Lenchus, DO, Regional Chief Medical Officer, Broward Health Medical Center27C O NT E NT SPg 10-11 IN F CUSDr Stephanie Plassmann, Senior Expert in Non-Clinical Drug Development
< Page 4 | Page 6 >